Warfarin associated intracerebral hemorrhage in Hong Kong Chinese

Abstract Objectives: Warfarin-associated intracerebral hemorrhage (WICH) is a serious neurological condition associated with significant mortality and morbidity. We aimed to study the clinical features and factors that predict clinical outcome of Chinese patients with WICH. Methods: Medical records of patients with spontaneous intracerebral hemorrhage (ICH) admitted to our hospital between July 2001 and June 2010 were reviewed and those with WICH were studied in detail retrospectively. Results: Fifty-one patients with WICH were studied. The mean age was 74·3 ± 10·5 years and 52·9% of the patients were female. The mean international normalized ratio (INR) on presentation was 2·9 ± 1·0. The median ICH volume was 23·3 (10·4–59·3) ml. The mortality rate at 3–6 months for WICH was 62·0%. Multivariate logistic analysis revealed that an initial ICH volume of > 20 ml (OR 34·4, P  =  0·037) and presence of intraventricular hemorrhage (OR 22·9, P  =  0·046) were independently associated with poor outcome. Supratherapeutic INR (INR > 3·0) on admission (P  =  0·724) and complete correction of INR within 24 hours after admission (P  =  0·486) were not independent predictors of poor outcome. The median ICH volumes did not differ between INR groups (18·2 (9·4–61·1) ml for INR ≤ 3 vs 27·3 (13·7–58·5) ml for INR > 3, P  =  0·718). Neurological deterioration (ND) was documented in 19 (63·3%) of the 30 patients included in a smaller sub-cohort, and was associated with poor neurological outcome (OR 20·7, P  =  0·027). Warfarin was resumed in 7 of the 20 survivors. There were two episodes of recurrent WICH and one episode of ischemic stroke during a mean follow-up duration of 5·4 years. In survivors who were not resumed on warfarin, there were two episodes of recurrent ICH and 12 episodes of ischemic vascular events (nine ischemic strokes) during a mean follow-up duration of 2·6 years. Conclusion: Warfarin-associated intracerebral hemorrhage is a very serious complication of warfarin therapy with high mortality and morbidity. Initial ICH volume, presence of intraventricular hemorrhage, and ND are independent predictors of clinical outcome.

[1]  Y. Seçil,et al.  Intracranial hemorrhages related with warfarin use and comparison of warfarin and acetylsalicylic acid. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[2]  S. Prabhakaran,et al.  Warfarin-associated intracerebral hemorrhage is increasing in prevalence in the United States. , 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[3]  M. Diringer,et al.  Hemostatic therapy should be used for acute treatment of anticoagulation-related intracerebral hemorrhage. , 2012, Stroke.

[4]  C. Molina,et al.  The role of hemostatic therapy in anticoagulation-associated intracerebral hemorrhage: intuition versus evidence. , 2012, Stroke.

[5]  J. Menzin,et al.  Failure to correct International Normalized Ratio and mortality among patients with warfarin‐related major bleeding: an analysis of electronic health records , 2012, Journal of thrombosis and haemostasis : JTH.

[6]  E. Russell,et al.  Blood Pressure Reduction, Decreased Diffusion on MRI, and Outcomes After Intracerebral Hemorrhage , 2012, Stroke.

[7]  C. Lau,et al.  Use of aspirin in Chinese after recovery from primary intracranial haemorrhage , 2011, Thrombosis and Haemostasis.

[8]  S. Greenberg,et al.  Warfarin-related intraventricular hemorrhage , 2011, Neurology.

[9]  Y. Palesch,et al.  Clinical Site Activation Times for Multicenter Clinical Trials: Lessons Learned From the Antihypertensive Treatment of Acute Cerebral Hemorrhage Trial , 2010 .

[10]  A. Rowe,et al.  Coagulation factor VIIa (recombinant) for warfarin-induced intracranial hemorrhage. , 2010, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[11]  A. Qureshi.  Antihypertensive treatment of acute cerebral hemorrhage* , 2010, Critical care medicine.

[12]  B. Ouyang,et al.  Acute Brain Infarcts After Spontaneous Intracerebral Hemorrhage: A Diffusion-Weighted Imaging Study , 2010, Stroke.

[13]  B. Norrving,et al.  Three-Year Survival and Stroke Recurrence Rates in Patients With Primary Intracerebral Hemorrhage , 2009, Stroke.

[14]  S. Kasner,et al.  Hematoma Growth in Oral Anticoagulant Related Intracerebral Hemorrhage , 2008, Stroke.

[15]  E. Wijdicks,et al.  Predictors of outcome in warfarin-related intracerebral hemorrhage. , 2008, Archives of neurology.

[16]  J. Broderick,et al.  Warfarin use leads to larger intracerebral hematomas , 2008, Neurology.

[17]  A. Cavallini,et al.  Warfarin-associated intracerebral hemorrhage , 2008, Neurological Sciences.

[18]  Mark Crowther,et al.  Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[19]  C. Anderson,et al.  Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial , 2008, The Lancet Neurology.

[20]  M. Aguilar,et al.  Anticoagulation in atrial fibrillation: selected controversies including optimal anticoagulation intensity, treatment of intracerebral hemorrhage , 2008, Journal of Thrombosis and Thrombolysis.

[21]  T. Wilkinson,et al.  The risk of recurrent stroke after intracerebral haemorrhage , 2007, Journal of Neurology, Neurosurgery & Psychiatry.

[22]  E. Wijdicks,et al.  Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP , 2006, Neurology.

[23]  M. Hartmann,et al.  Hematoma Growth and Outcome in Treated Neurocritical Care Patients With Intracerebral Hemorrhage Related to Oral Anticoagulant Therapy: Comparison of Acute Treatment Strategies Using Vitamin K, Fresh Frozen Plasma, and Prothrombin Complex Concentrates , 2006, Stroke.

[24]  J. Broderick,et al.  Asymptomatic sinovenous thrombosis in a healthy neonate , 2006, Neurology.

[25]  T. Steiner,et al.  Intracerebral Hemorrhage Associated With Oral Anticoagulant Therapy: Current Practices and Unresolved Questions , 2006, Stroke.

[26]  Eric E. Smith,et al.  Timing of Fresh Frozen Plasma Administration and Rapid Correction of Coagulopathy in Warfarin-Related Intracerebral Hemorrhage , 2006, Stroke.

[27]  S. Avikainen,et al.  Long term survival after primary intracerebral haemorrhage: a retrospective population based study , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[28]  R. Hart,et al.  Avoiding Central Nervous System Bleeding During Antithrombotic Therapy: Recent Data and Ideas , 2005, Stroke.

[29]  T. Brott,et al.  Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. , 2004, Mayo Clinic proceedings.

[30]  S. Greenberg,et al.  Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage , 2004, Neurology.

[31]  A. Dávalos,et al.  Early neurologic deterioration in intracerebral hemorrhage , 2004, Neurology.

[32]  D. Singer,et al.  The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. , 2004, Archives of internal medicine.

[33]  A. Algra,et al.  Risk Factors for Intracerebral Hemorrhage in the General Population: A Systematic Review , 2003, Stroke.

[34]  J. C. Sørensen,et al.  Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[35]  A. Algra,et al.  Long-term prognosis after recovery from primary intracerebral hemorrhage , 2002, Neurology.

[36]  O. Benavente,et al.  Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage , 2001, Neurology.

[37]  J. Webster,et al.  Prediction of Functional Outcome and In-Hospital Mortality After Admission With Oral Anticoagulant–Related Intracerebral Hemorrhage , 2000, Stroke.

[38]  E. K. Louis,et al.  Predicting deterioration in patients with lobar haemorrhages , 1999, Journal of neurology, neurosurgery, and psychiatry.

[39]  M. Frankel,et al.  Predictors of early deterioration and mortality in black Americans with spontaneous intracerebral hemorrhage. , 1995, Stroke.

[40]  R. Hart,et al.  Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. , 1995, Stroke.

[41]  S. Mayer,et al.  Neurologic deterioration in noncomatose patients with supratentorial intracerebral hemorrhage , 1994, Neurology.

[42]  E. Hylek,et al.  Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin , 1994, Annals of Internal Medicine.

[43]  I. Kunnamo,et al.  Anticoagulant treatment as a risk factor for primary intracerebral haemorrhage. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[44]  J. V. van Swieten,et al.  Intracerebral hematomas during anticoagulant treatment. , 1990, Stroke.

[45]  W. Elliott.  Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomized pilot trial , 2009 .

[46]  S. Mayer,et al.  Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. , 2007, Mayo Clinic proceedings.

[47]  J. Broderick,et al.  Location and outcome of anticoagulant-associated intracerebral hemorrhage , 2006, Neurocritical care.

[48]  D. Brody,et al.  Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage , 2005, Neurocritical care.

[49]  P. Austin,et al.  Rate of stroke recurrence in patients with primary intracerebral hemorrhage. , 2000, Stroke.

[50]  ThomasBrott,et al.  Early Hemorrhage Growth in Patients With Intracerebral Hemorrhage , 1997 .